CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Perdagangan Quince Therapeuticks Inc - QNCX CFD

1.5486
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0328
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024874%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.002651%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.5486
Open* 1.4886
1-Year Change* -75.76%
Day's Range* 1.4886 - 1.5586
52 wk Range 0.54-6.80
Average Volume (10 days) 5.96M
Average Volume (3 months) 47.40M
Market Cap 56.59M
P/E Ratio -100.00K
Shares Outstanding 36.28M
Revenue N/A
EPS -1.61
Dividend (Yield %) N/A
Beta 1.38
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2023 1.5486 0.0600 4.03% 1.4886 1.5686 1.4886
Mar 30, 2023 1.5486 0.0500 3.34% 1.4986 1.5686 1.4886
Mar 29, 2023 1.5386 0.0499 3.35% 1.4887 1.5686 1.4687
Mar 28, 2023 1.4687 0.0100 0.69% 1.4587 1.5186 1.4487
Mar 27, 2023 1.4487 0.0200 1.40% 1.4287 1.5486 1.4287
Mar 24, 2023 1.4587 0.0600 4.29% 1.3987 1.4787 1.3488
Mar 23, 2023 1.3588 -0.0899 -6.21% 1.4487 1.4687 1.3488
Mar 22, 2023 1.4187 0.0200 1.43% 1.3987 1.4687 1.3688
Mar 21, 2023 1.4187 0.0000 0.00% 1.4187 1.5186 1.3388
Mar 20, 2023 0.8196 0.0004 0.05% 0.8192 0.8360 0.7892
Mar 17, 2023 0.8188 -0.0171 -2.05% 0.8359 0.8359 0.7848
Mar 16, 2023 0.8193 -0.0066 -0.80% 0.8259 0.8557 0.7919
Mar 15, 2023 0.8410 -0.0382 -4.34% 0.8792 0.8792 0.8155
Mar 14, 2023 0.8716 -0.0339 -3.74% 0.9055 0.9155 0.8691
Mar 13, 2023 0.8791 -0.0663 -7.01% 0.9454 0.9454 0.8656
Mar 10, 2023 0.9237 -0.0326 -3.41% 0.9563 0.9752 0.9237
Mar 9, 2023 0.9743 -0.0247 -2.47% 0.9990 1.0490 0.9643
Mar 8, 2023 0.9832 0.0080 0.82% 0.9752 0.9950 0.9393
Mar 7, 2023 0.9591 0.0079 0.83% 0.9512 0.9784 0.9491
Mar 6, 2023 0.9667 0.0023 0.24% 0.9644 0.9868 0.9433

Quince Therapeuticks Inc Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 52.015 90.318 78.893 39.168 12.119
Selling/General/Admin. Expenses, Total 26.012 29.523 17.586 8.954 2.034
Research & Development 25.178 60.795 61.307 30.214 10.085
Operating Income -52.015 -90.318 -78.893 -39.168 -12.119
Interest Income (Expense), Net Non-Operating 1.068 0.62 2.044 2.188 -0.357
Net Income Before Taxes -51.944 -89.945 -76.849 -36.98 -12.476
Net Income After Taxes -51.66 -89.945 -76.849 -36.98 -12.476
Net Income Before Extra. Items -51.66 -89.945 -76.849 -36.98 -12.476
Total Extraordinary Items
Net Income -51.66 -89.945 -76.849 -36.98 -12.476
Income Available to Common Excl. Extra. Items -51.66 -89.945 -76.849 -36.98 -12.476
Income Available to Common Incl. Extra. Items -51.66 -89.945 -76.849 -36.98 -12.476
Diluted Net Income -51.66 -89.945 -76.849 -36.98 -12.476
Diluted Weighted Average Shares 33.4965 29.7185 29.1762 19.0319 26.0133
Diluted EPS Excluding Extraordinary Items -1.54225 -3.02657 -2.63396 -1.94305 -0.4796
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -1.52624 -3.02657 -2.63396 -1.94305 -0.4796
Other, Net -0.997 -0.247
Unusual Expense (Income) 0.825
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0 0 0
Total Operating Expense 6.319 7.62 16.258 21.863 23.544
Selling/General/Admin. Expenses, Total 3.551 4.344 9.059 9.106 8.331
Research & Development 2.768 2.451 7.199 12.757 15.213
Operating Income -6.319 -7.62 -16.258 -21.863 -23.544
Interest Income (Expense), Net Non-Operating 0.536 0.315 0.145 0.072 0.105
Net Income Before Taxes -5.534 -7.921 -16.848 -21.641 -23.399
Net Income After Taxes -5.534 -7.921 -16.564 -21.641 -23.399
Net Income Before Extra. Items -5.534 -7.921 -16.564 -21.641 -23.399
Net Income -5.534 -7.921 -16.564 -21.641 -23.399
Income Available to Common Excl. Extra. Items -5.534 -7.921 -16.564 -21.641 -23.399
Income Available to Common Incl. Extra. Items -5.534 -7.921 -16.564 -21.641 -23.399
Diluted Net Income -5.534 -7.921 -16.564 -21.641 -23.399
Diluted Weighted Average Shares 35.7117 35.6128 32.467 30.1345 29.962
Diluted EPS Excluding Extraordinary Items -0.15496 -0.22242 -0.51018 -0.71815 -0.78095
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.15496 -0.19925 -0.51018 -0.71815 -0.78095
Other, Net 0.249 -0.616 -0.735 0.15 0.04
Unusual Expense (Income) 0 0.825
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 111.673 137.862 106.056 72.584 7.537
Cash and Short Term Investments 106.802 133.82 99.864 71.716 7.343
Cash 40.27 35.69 4.074 11.259 7.343
Cash & Equivalents 15.954 16.151 46.155 11.815 0
Short Term Investments 50.578 81.979 49.635 48.642 0
Prepaid Expenses 3.376 3.348 5.504 0.766 0.141
Other Current Assets, Total 1.495 0.694 0.688 0.102 0.053
Total Assets 133.228 189.466 124.37 72.877 7.718
Property/Plant/Equipment, Total - Net 1.428 1.101 1.334 0.283 0.122
Property/Plant/Equipment, Total - Gross 2.387 1.716 1.617 0.378 0.166
Accumulated Depreciation, Total -0.959 -0.615 -0.283 -0.095 -0.044
Other Long Term Assets, Total 0.194 0.039 0.217 0.01 0.059
Total Current Liabilities 14.222 16.996 8.892 1.457 1.763
Accounts Payable 4.911 3.555 3.075 0.495 0.517
Accrued Expenses 9.311 13.441 5.817 0.962 1.246
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 14.642 17.204 8.892 1.457 10.82
Total Long Term Debt 0 0 0 0 7.171
Long Term Debt 0 7.171
Other Liabilities, Total 0.42 0.208 0 1.886
Total Equity 118.586 172.262 115.478 71.42 -3.102
Redeemable Preferred Stock 0 104.046 17.178
Common Stock 0.03 0.029 0.027 0.009 0.009
Additional Paid-In Capital 355.234 318.574 185.196 0.239 0.06
Retained Earnings (Accumulated Deficit) -236.599 -146.654 -69.805 -32.825 -20.349
Other Equity, Total -0.079 0.313 0.06 -0.049 0
Total Liabilities & Shareholders’ Equity 133.228 189.466 124.37 72.877 7.718
Total Common Shares Outstanding 30.0744 29.5432 26.8694 26.0133 26.0133
Long Term Investments 19.933 50.464 16.763
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 96.353 111.673 119.427 135.843 149.885
Cash and Short Term Investments 91.524 106.802 114.412 129.95 147.035
Cash 27.403 40.27 8.357 5.744 24.569
Cash & Equivalents 32.361 15.954 36.6 47.049 38.246
Short Term Investments 31.76 50.578 69.455 77.157 84.22
Prepaid Expenses 2.784 3.376 4.52 5.455 2.293
Other Current Assets, Total 2.045 1.495 0.495 0.438 0.557
Total Assets 116.13 133.228 147.416 161.39 174.522
Property/Plant/Equipment, Total - Net 0.573 1.428 1.655 1.886 0.878
Property/Plant/Equipment, Total - Gross 1.569 2.387 2.53 2.674 1.579
Accumulated Depreciation, Total -0.996 -0.959 -0.875 -0.788 -0.701
Long Term Investments 19.175 19.933 26.141 23.516 23.72
Other Long Term Assets, Total 0.029 0.194 0.193 0.145 0.039
Total Current Liabilities 9.71 14.222 14.154 18.537 17.867
Accounts Payable 3.731 4.911 2.88 7.193 2.845
Accrued Expenses 5.979 9.311 11.274 11.344 15.022
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 9.75 14.642 14.764 19.31 18.038
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.04 0.42 0.61 0.773 0.171
Total Equity 106.38 118.586 132.652 142.08 156.484
Common Stock 0.03 0.03 0.03 0.03 0.029
Additional Paid-In Capital 365.096 355.234 345.751 333.427 326.006
Retained Earnings (Accumulated Deficit) -258.24 -236.599 -213.2 -191.494 -169.74
Other Equity, Total -0.506 -0.079 0.071 0.117 0.189
Total Liabilities & Shareholders’ Equity 116.13 133.228 147.416 161.39 174.522
Total Common Shares Outstanding 30.1496 30.0744 29.8673 29.6558 29.5759
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -51.66 -89.945 -76.849 -36.98 -12.476
Cash From Operating Activities -44.038 -62.932 -50.818 -33.277 -11.695
Cash From Operating Activities 0.204 0.344 0.332 0.188 0.051
Non-Cash Items 17.437 30.93 15.472 1.611 1.12
Cash Interest Paid 0.001
Changes in Working Capital -9.735 -4.261 10.227 1.904 -0.39
Cash From Investing Activities 18.002 58.952 -52.431 -17.747 -46.754
Capital Expenditures -0.133 -0.18 -0.052 -0.055 -0.212
Other Investing Cash Flow Items, Total 18.135 59.132 -52.379 -17.692 -46.542
Cash From Financing Activities 0.707 6.808 118.876 77.366 75.928
Issuance (Retirement) of Stock, Net 0.756 6.808 118.91 77.925 75.678
Issuance (Retirement) of Debt, Net -0.049 0 -0.034 -0.559 0.25
Net Change in Cash -25.145 2.883 15.627 26.342 17.479
Foreign Exchange Effects 0.184 0.055
Deferred Taxes -0.284
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -51.66 -46.126 -38.205 -21.641 -89.945
Cash From Operating Activities -44.038 -38.203 -31.506 -16.091 -62.932
Cash From Operating Activities 0.204 0.162 0.122 0.038 0.344
Non-Cash Items 17.437 16.03 14.565 9.375 30.93
Changes in Working Capital -9.735 -7.985 -7.704 -3.863 -4.261
Cash From Investing Activities 18.002 -0.664 8.162 13.413 58.952
Capital Expenditures -0.133 -0.055 -0.005 -0.005 -0.18
Other Investing Cash Flow Items, Total 18.135 -0.609 8.167 13.418 59.132
Cash From Financing Activities 0.707 0.725 0.73 0.622 6.808
Issuance (Retirement) of Stock, Net 0.756 0.756 0.742 0.622 6.808
Net Change in Cash -25.145 -37.915 -22.796 -2.16 2.883
Issuance (Retirement) of Debt, Net -0.049 -0.031 -0.012 0
Foreign Exchange Effects 0.184 0.227 -0.182 -0.104 0.055
Deferred Taxes -0.284 -0.284 -0.284
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Lamond (David A.) Individual Investor 10.1543 3683658 1634720 2022-01-31
Dominy (Stephen S) Individual Investor 3.9631 1437674 763 2022-01-31
Lynch (Casey C) Individual Investor 3.2544 1180580 -120000 2022-01-31
EPIQ Capital Group, LLC Investment Advisor 2.9115 1056191 -1000478 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 2.4701 896084 -61145 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.3524 853391 -18615 2022-12-31 LOW
Pfizer Inc Corporation 1.6539 600000 -1456377 2021-12-31 MED
Millennium Management LLC Hedge Fund 1.6424 595801 137810 2022-12-31 HIGH
Low (Philip S) Individual Investor 1.2551 455309 455309 2022-05-19
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9169 332627 -165208 2022-12-31 LOW
Thye (Dirk) Individual Investor 0.7744 280911 280911 2022-05-19
Lowe (Christopher P) Individual Investor 0.7305 265000 175000 2022-03-03 LOW
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 0.6904 250458 -264583 2022-12-31 HIGH
Smith (Karen L) Individual Investor 0.5367 194690 194690 2022-05-19 LOW
Alphabet, Inc. Venture Capital 0.5213 189122 0 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4248 154100 -180125 2022-12-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.4239 153788 0 2022-12-31 MED
Holsinger (Leslie) Individual Investor 0.3985 144580 -10920 2022-06-06
Detke (Michael J) Individual Investor 0.3859 140000 140000 2022-03-03
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3779 137086 -9128 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Biotechnology & Medical Research (NEC)

269 East Grand Ave
94080

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Biaya inap posisi Long -0.0156%
Biaya inap posisi short -0.0063%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

US100

13,186.80 Price
+1.680% 1D Chg, %
Biaya inap posisi Long -0.0249%
Biaya inap posisi short 0.0027%
Waktu biaya inap 21:00 (UTC)
Spread 3.0

Gold

1,969.66 Price
-0.550% 1D Chg, %
Biaya inap posisi Long -0.0185%
Biaya inap posisi short 0.0102%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

BTC/USD

28,401.90 Price
-0.400% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda